This webinar is jointly provided by CancerNet, LLC. and Amedo, LLC.
This activity is supported in part by an independent education grant from Amgen Inc. and, Sanofi Genzyme.
This activity will cover topics on the diagnosis, treatment, and management of patients with multiple myeloma. Upon completion of this activity, participants should be better able to:
This activity is designed to meet the educational needs of hematologists/oncologists, physician assistants, nurse practitioners, nurses involved in the treatment of patients with multiple myeloma.
Date and Time:
This webinar will be held on:
Keith Stewart, MBChB, MRCP
Cancer and Director of the Princess Margaret Cancer Program
UHN, Regional Vice-President
Toronto Central South Regional Cancer Program
Ontario Health, Toranto, Canada
Joseph Mikhael, MD
Applied Cancer Research and Drug Discovery, Translational Genomics Research Institute (TGen)
City of Hope Cancer Center
Chief Medical Officer
International Myeloma Foundation
Amrita Krishnan, MD
Director of the Judy and Bernard Briskin Center for Multiple Myeloma Research
Department of Hematology & Hematopoietic Cell Transplantation
City of Hope Comprehensive Cancer Center
Ajai Chari, MD
Professor of Medicine
Director of Clinical Research in the Multiple Myeloma Program
Associate Director of Clinical Research
Mt Sinai Cancer Clinical Trials Office
Mount Sinai Hospital
New York, NY
Tanya M. Wildes, MD, MSCI
Associate Professor of Medicine
Division of Medical Oncology
Washington University School of Medicine
660 South Euclid Avenue
St Louis, MO
Nina Shah, MD
Department of Medicine
San Francisco, CA
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and CancerNet LLC. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
Amedco LLC designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™ for physicians and 3.25 contact hours for nurses. Learners should claim only the credit commensurate with the extent of their participation in the activity.
Planners and Managers
Instructions for Participation and Credit
There are no fees for participating and receiving CME/CE credit for this enduring activity. To receive CME/CE credit participants must:
Certificates will be emailed to the participant.
Disclosure of Unlabeled Use
CancerNet and Amedco require that faculty participating in any CME/CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Amedco makes every effort to develop CME/CE activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME/CE questions, please contact: Amedco at: email@example.com
For questions regarding the content, please contact: CancerNet at firstname.lastname@example.org